Article Information
History
- October 21, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jonathan Volpatti1,2,
- Yukari Endo1,
- Linda Groom3,
- Stephanie Brennan1,2,
- Ramil Noche1,
- William Zuercher4,
- Peter Roy2,
- Robert T. Dirksen3 and
- James J. Dowling1,2,*
- 1Program for Genetics and Genome Biology, Hospital for Sick Children, Toronto, CA
- 2Department of Molecular Genetics, University of Toronto, Toronto, CA
- 3Department of Pharmacology, University of Rochester, Rochester, NY, USA
- 4UNC Eshelman School of Pharmacy, SGC Center for Chemical Biology, University of North Carolina at Chapel Hill, NC, USA
- ↵*To Whom Correspondence Should be Addressed: James J. Dowling, MD, PhD, Program of Genetics and Genome Biology and Division of Neurology, Hospital for Sick Children, 686 Bay Street, Toronto, ON CAN M5G0A4, james.dowling{at}sickkids.ca
Posted October 21, 2019.
Identification of drug modifiers for RYR1 related myopathy using a multi-species discovery pipeline
